“…One of the main non-psychotropic phytocannabinoids is CBG, whose biosynthesis is characteristic especially for plants of the species Cannabis sativa L. (Beleggia et al, 2023). Its synthesis primarily depends on plant genotype; however, due to the complexity of the process of extraction and purification of the compound, CBG used in medicine often comes from in vitro enzymatic synthesis (Qamar et al, 2021;Go et al, 2023). Its biological action is based on the activation of cannabinoid receptors (CB1/2) (Makwana et al, 2015;Navarro et al, 2018;Di Meo et al, 2022), resulting in the modulation of expression of proinflammatory proteins, such as TNF-α, IL-1β, IL-6, IL-10, interferon-γ, and prostaglandin E2 (Borrelli et al, 2013;Petrosino et al, 2018;Nachnani et al, 2021).…”